Company · CIK 0000897075 · SIC 2836 — Biological Products, (No Diagnostic Substances)
REPROS THERAPEUTICS INC. · RPRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2018 DUForm 4 → | Jan 31, 10:03 am EST | Michael WyllieDirector | 49,359 | $0.67 | $33,071 | 0 | — | plan? |
| Jan 29, 2018 DUForm 4 → | Jan 31, 10:02 am EST | Patrick FourteauDirector | 40,000 | $0.67 | $26,800 | 0 | — | plan? |
| Jan 29, 2018 DUForm 4 → | Jan 31, 10:01 am EST | Saira RamasastryDirector | 40,000 | $0.67 | $26,800 | 0 | — | plan? |
| Jan 29, 2018 DUForm 4 → | Jan 31, 9:59 am EST | Nola E MastersonDirector | 40,000 | $0.67 | $26,800 | 0 | — | plan? |
| Jan 29, 2018 DUForm 4 → | Jan 31, 9:57 am EST | Daniel F CainDirector | 51,000 | $0.67 | $34,170 | 0 | — | plan? |
| Jan 29, 2018 UForm 4 → | Jan 31, 9:54 am EST | Katherine AndersonCHIEF FINANCIAL OFFICER | 83,875 | $0.67 | $56,196 | 0 | — | plan? |
| Jul 3, 2017 AForm 4 → | Jul 5, 4:00 pm EDT | Katherine AndersonChief Financial Officer | 10,000 | — | — | 83,875 | — | plan? |
| Jun 1, 2017 AForm 4 → | Jun 2, 4:00 pm EDT | Katherine AndersonChief Financial Officer | 10,000 | — | — | 73,875 | — | plan? |
| May 1, 2017 AForm 4 → | May 1, 4:01 pm EDT | Katherine AndersonChief Financial Officer | 10,000 | — | — | 63,875 | — | plan? |
| Apr 3, 2017 AForm 4 → | Apr 4, 4:13 pm EDT | Katherine AndersonChief Financial Officer | 10,000 | — | — | 53,875 | — | plan? |
| Mar 1, 2017 AForm 4 → | Mar 2, 4:26 pm EST | Katherine AndersonChief Financial Officer | 10,000 | — | — | 43,875 | — | plan? |
| Feb 13, 2017 AForm 4 → | Feb 15, 4:35 pm EST | Michael WyllieDirector | 40,000 | — | — | 49,359 | — | plan? |
| Feb 13, 2017 AForm 4 → | Feb 15, 4:32 pm EST | Saira RamasastryDirector | 40,000 | — | — | 40,000 | — | plan? |
| Feb 13, 2017 AForm 4 → | Feb 15, 4:30 pm EST | Daniel F CainDirector | 40,000 | — | — | 51,000 | — | plan? |
| Feb 13, 2017 AForm 4 → | Feb 15, 4:28 pm EST | Nola E MastersonDirector | 40,000 | — | — | 40,000 | — | plan? |
| Feb 13, 2017 AForm 4 → | Feb 15, 4:26 pm EST | Patrick FourteauDirector | 40,000 | — | — | 40,000 | — | plan? |
| Feb 1, 2017 AForm 4 → | Feb 3, 4:40 pm EST | Katherine AndersonChief Financial Officer | 10,000 | — | — | 33,875 | — | plan? |
| Dec 9, 2016 PForm 4 → | Dec 9, 5:13 pm EST | Joseph PodolskiPresident and CEO, Director | 20,000 | $1.60 | $32,000 | 107,422 | +22.9% | plan? |
| Nov 21, 2016 SForm 4 → | Nov 23, 4:07 pm EST | Nola E MastersonDirector | 3,305 | $1.95 | $6,445 | 0 | −100% | plan? |
| Feb 18, 2016 PForm 4 → | Feb 19, 4:06 pm EST | Joseph PodolskiPresident and CEO, Director | 10,000 | $0.93 | $9,300 | 87,422 | +12.9% | plan? |
| Jan 27, 2016 PForm 4 → | Jan 28, 4:12 pm EST | Katherine AndersonChief Financial Officer | 12,000 | $1.08 | $12,960 | 23,875 | +101% | plan? |
| Jan 25, 2016 PForm 4 → | Jan 28, 4:12 pm EST | J. F. WernickeChief Medical Officer | 10,000 | $1.11 | $11,126 | 10,000 | — | plan? late |
| Jan 6, 2016 PForm 4 → | Jan 7, 4:44 pm EST | Joseph PodolskiPresident and CEO, Director | 11,677 | $1.18 | $13,794 | 77,422 | +17.8% | plan? |